[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370693-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370693-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","advances-in-understanding-the-mechanisms-of-the-human-papillomavirus-oncoproteins","Advances in understanding the mechanisms of the human papillomavirus oncoproteins","","High-risk human papillomaviruses drive nearly all cervical cancers and additional oropharyngeal and anogenital malignancies through the coordinated action of the oncoproteins E6 and E7. These proteins rewire signalling networks controlling proliferation, cell-cycle progression and survival, enabling malignant transformation. Beyond established pathways such as E7-mediated pRb degradation and E6-mediated p53 degradation, recent findings reveal additional oncogenic roles involving epigenetic alterations, cellular plasticity and genomic instability. This review synthesizes current mechanistic advances and highlights emerging therapeutic target opportunities in HPV-associated cancers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/advances-in-understanding-the-mechanisms-of-the-human-papillomavirus-oncoproteins/370693/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/advances-in-understanding-the-mechanisms-of-the-human-papillomavirus-oncoproteins/370693.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What roles do HPV oncoproteins E6 and E7 play in cancer development?","Question",{"text":63,"@type":64},"E6 and E7 jointly manipulate multiple cellular pathways that regulate proliferation, cell-cycle progression, and survival, ultimately enabling malignant transformation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which mechanisms are most established for HPV E6 and E7 oncogenesis?",{"text":68,"@type":64},"E7 promotes aberrant cell-cycle entry by degrading the tumour suppressor pRb and disrupting the G1/S checkpoint, while E6 promotes continuous proliferation and survival by degrading p53.",{"name":70,"@type":61,"acceptedAnswer":71},"What newer oncogenic functions are emphasized in this review?",{"text":72,"@type":64},"The review highlights newly uncovered pro-oncogenic functions of E6 and E7, particularly linked to epigenetic modifications, cellular plasticity, and genomic instability, which are increasingly recognized as drivers of malignant development.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370693,1790472402,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Biochemical Society Transactions (2025) 00 1–13 [https://doi.org/10.1042/BST20253041](https://doi.org/10.1042/BST20253041)  \nReview Article  \nAdvances in understanding the mechanisms of the human papillomavirus oncoproteins  \nDenise Ijeoma Obanya, Louisa M. Wootton and Ethan L. Morgan School of Life Sciences, University of Sussex, Brighton, U.K  \nCorrespondence: Ethan L. Morgan ([e.l.morgan@sussex.ac.uk](e.l.morgan@sussex.ac.uk))  \nReceived: 13 February 2025  \nAccepted: 2 May 2025  \nVersion of Record Published: 16 May 2025  \nHigh-risk human papillomaviruses (HPVs) are responsible for almost all cervical cancer cases and a growing number of oropharyngeal and anogenital cancers. The primary HPV oncoproteins, E6 and E7, act together to manipulate multiple cellular pathways that can ultimately result in malignant transformation. This includes the deregulation of several signalling pathways that regulate cell proliferation, cell cycle progression and cell survival. Although multiple functions of HPV E6 and E7 in driving oncogenesis are well known, recent studies have uncovered novel oncogenic functions of the HPV oncoproteins, including the manipulation of emerging mechanisms of cancer development, such as epigenetic modifications, cellular plasticity and genomic instability. This review explores current advances in understanding how the HPV oncoproteins interact with these cellular processes, highlighting potential therapeutic targets in HPV-associated cancers.  \nIntroduction  \nAround 15% of cancers are caused by pathogens, with around a third of these caused by human papillomavirus (HPV) infection [ 1] . HPVs are a diverse group of DNA viruses that infect host keratinocytes in the stratified epithelia [2,3]. The majority of HPVs have a common genome organisation and express a similar pattern of viral genes [4–6]. HPVs can broadly be classified as high-risk (HR) or low-risk based on their association with the development of malignancies [7] . Whilst the association between HR-HPV infection and cancer development is well established, only 10–20% of infections persist and lead to malignancy [8]. To date, around 15 HR-HPV types have been identified, with HPV16 and HPV18 being the most common, accounting for about 70% of cervical cancers [5] . Additionally, HR-HPV infection is associated with four other ano-genital cancers (anal, penile, vaginal and vulvar) and oropharyngeal cancers [7]. The primary drivers of HPV-mediated oncogenesis are the major oncoproteins E6 and E7, with the minor oncoprotein E5 playing a smaller, supporting role [9]. These proteins deregulate multiple signalling pathways and cellular processes, providing an environment conducive to allow viral replication and persistence. HPV infection drives cell cycle progression, proliferation and survival through the function of these proteins, ultimately promoting malignant progression [5] . The most well-studied mechanisms are the degradation of the tumour suppressor retinoblastoma protein (pRb) by E7, causing aberrant cell cycle entry via deregulation of the G1/S checkpoint [ 10,11], and the E6-mediated degradation of p53, promoting continuous proliferation and survival [ 12,13] . The oncogenic mechanisms of HPV E5 are less well studied, but it plays a role in promoting proliferation, primarily via epidermal growth factor receptor (EGFR) signalling [ 14,15]. The mechanistic understanding of how the HPV oncoproteins function to promote oncogenic development has been greatly expanded over the past 40 years. However, novel functions continue to be uncovered, particularly as new oncogenic mechanisms in general are discovered as technical advances are made. Considering this, here we highlight recently discovered pro-oncogenic functions of HPV E6 and E7, particularly in the areas of epigenetics, genomic instability and cellular plasticity, which have become increasingly recognised as important drivers of malignant development in multiple cancers [ 16–18] .  \nEpigenetic modific","cbCaiuAbR2MK30QG","https://ap.wps.com/l/cbCaiuAbR2MK30QG","pdf",954954,13,"English","# Introduction\n# Epigenetic modifications\n## DNA methylation","[{\"question\":\"What roles do HPV oncoproteins E6 and E7 play in cancer development?\",\"answer\":\"E6 and E7 jointly manipulate multiple cellular pathways that regulate proliferation, cell-cycle progression, and survival, ultimately enabling malignant transformation.\"},{\"question\":\"Which mechanisms are most established for HPV E6 and E7 oncogenesis?\",\"answer\":\"E7 promotes aberrant cell-cycle entry by degrading the tumour suppressor pRb and disrupting the G1/S checkpoint, while E6 promotes continuous proliferation and survival by degrading p53.\"},{\"question\":\"What newer oncogenic functions are emphasized in this review?\",\"answer\":\"The review highlights newly uncovered pro-oncogenic functions of E6 and E7, particularly linked to epigenetic modifications, cellular plasticity, and genomic instability, which are increasingly recognized as drivers of malignant development.\"}]","Advances in understanding the mechanisms of the human papillomavirus oncoproteins | PDF",1790189857,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4207d0db4f330ca06b21fdc5e133389c.webp",983,1301,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b32f1e89c9eda79b583b21c2a8fc4ce.webp",982,1299,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0bd3bcd48adf8acf6eb31722412ce49e.webp",981,1298,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54c4916ef92b84dc074ed26bb2475aae.webp",980,1297]